(Q42791831)

7 November 2017

Treg and T-effector cells in autoimmune CNS inflammation: a delicate balance, easily disturbed (English)

1 reference

7 November 2017

Stephen M Anderton

1

1 reference

PubMed ID

21110316

7 November 2017

language of work or name

English

0 references

publication date

1 December 2010

1 reference

European Journal of Immunology

7 November 2017

1 reference

7 November 2017

40

1 reference

7 November 2017

12

1 reference

7 November 2017

3321-3324

1 reference

Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system.

7 November 2017

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041100

Foxp3+ regulatory T cells in the control of experimental CNS autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041100

7 January 2021

Regulatory T cells in the control of inflammatory demyelinating diseases of the central nervous system.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041100

7 January 2021

Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041100

7 January 2021

Reduced Treg frequency in LFA-1-deficient mice allows enhanced T effector differentiation and pathology in EAE.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041100

7 January 2021

Leukocyte functional antigen 1 lowers T cell activation thresholds and signaling through cytohesin-1 and Jun-activating binding protein 1.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041100

7 January 2021

LFA-1: more than just T cell Velcro

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041100

7 January 2021

LFA-1 decreases the antigen dose for T cell activation in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041100

7 January 2021

Encephalitogenic T cells use LFA-1 for transendothelial migration but not during capture and initial adhesion strengthening in healthy spinal cord microvessels in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041100

7 January 2021

The inflamed central nervous system drives the activation and rapid proliferation of Foxp3+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041100

7 January 2021

CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041100

7 January 2021

Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041100

7 January 2021

CD18 is required for optimal development and function of CD4+CD25+ T regulatory cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041100

7 January 2021

beta2-integrins in demyelinating disease: not adhering to the paradigm

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041100

7 January 2021

Effector and suppressor roles for LFA-1 during the development of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041100

7 January 2021

LFA-1 is critical for regulatory T cell homeostasis and function

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041100

7 January 2021

Gene transfer into CD4+ T lymphocytes: green fluorescent protein-engineered, encephalitogenic T cells illuminate brain autoimmune responses.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041100

7 January 2021

IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041100

7 January 2021

Regulation of experimental autoimmune encephalomyelitis by CD4+, CD25+ and CD8+ T cells: analysis using depleting antibodies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041100

7 January 2021

CD4+CD25+ regulatory T cells limit the risk of autoimmune disease arising from T cell receptor crossreactivity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041100

7 January 2021

Thymocyte deletion can bias Treg formation toward low-abundance self-peptide

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041100

7 January 2021

Enhanced selection of FoxP3+ T-regulatory cells protects CTLA-4-deficient mice from CNS autoimmune disease.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041100

7 January 2021

Identifiers

DOI

10.1002/EJI.201041100

1 reference

7 November 2017

1 reference

PubMed ID

21110316